These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 32520759)
21. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future. van der Post RS; Gullo I; Oliveira C; Tang LH; Grabsch HI; O'Donovan M; Fitzgerald RC; van Krieken H; Carneiro F Adv Exp Med Biol; 2016; 908():371-91. PubMed ID: 27573781 [TBL] [Abstract][Full Text] [Related]
22. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene]. Svrcek M Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246 [No Abstract] [Full Text] [Related]
23. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748 [TBL] [Abstract][Full Text] [Related]
24. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512 [TBL] [Abstract][Full Text] [Related]
25. Identification of c.1531C>T Pathogenic Variant in the Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923 [TBL] [Abstract][Full Text] [Related]
28. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management. Rocha JP; Gullo I; Wen X; Devezas V; Baptista M; Oliveira C; Carneiro F Histopathology; 2018 Dec; 73(6):878-886. PubMed ID: 30014492 [TBL] [Abstract][Full Text] [Related]
29. Surveillance Endoscopy in the Management of Hereditary Diffuse Gastric Cancer Syndrome. Friedman M; Adar T; Patel D; Lauwers GY; Yoon SS; Mullen JT; Chung DC Clin Gastroenterol Hepatol; 2021 Jan; 19(1):189-191. PubMed ID: 31678201 [TBL] [Abstract][Full Text] [Related]
30. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370 [TBL] [Abstract][Full Text] [Related]
31. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Humar B; Blair V; Charlton A; More H; Martin I; Guilford P Cancer Res; 2009 Mar; 69(5):2050-6. PubMed ID: 19223545 [TBL] [Abstract][Full Text] [Related]
32. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383 [TBL] [Abstract][Full Text] [Related]
33. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers. van Dieren JM; Kodach LL; den Hartog P; van der Kolk LE; Sikorska K; van Velthuysen MF; van Sandick JW; Koemans WJ; Snaebjornsson P; Cats A Endoscopy; 2020 Oct; 52(10):839-846. PubMed ID: 32408363 [TBL] [Abstract][Full Text] [Related]
34. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Charlton A; Blair V; Shaw D; Parry S; Guilford P; Martin IG Gut; 2004 Jun; 53(6):814-20. PubMed ID: 15138207 [TBL] [Abstract][Full Text] [Related]
35. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease. Gullo I; Devezas V; Baptista M; Garrido L; Castedo S; Morais R; Wen X; Rios E; Pinheiro J; Pinto-Ribeiro I; Ferreira RM; Preto J; Santos-Antunes J; Marques M; Campos M; Almeida F; Espinheira MDC; Amil Dias J; Figueiredo C; Oliveira C; Trindade E; Carneiro F Gastrointest Endosc; 2018 Jun; 87(6):1566-1575. PubMed ID: 29454568 [TBL] [Abstract][Full Text] [Related]
37. Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature. Hamilton LE; Jones K; Church N; Medlicott S BMC Gastroenterol; 2013 Jul; 13():114. PubMed ID: 23849133 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients. Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054 [TBL] [Abstract][Full Text] [Related]
39. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance. Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650 [TBL] [Abstract][Full Text] [Related]
40. Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis. Green BL; Gamble LA; Diggs LP; Nousome D; Patterson JC; Joughin BA; Gasmi B; Lux SC; Samaranayake SG; Miettinen M; Quezado M; Hernandez JM; Yaffe MB; Davis JL Mol Cancer Res; 2023 Dec; 21(12):1356-1365. PubMed ID: 37707375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]